PMC:7534795 / 41163-41387 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T193","span":{"begin":105,"end":114},"obj":"Body_part"}],"attributes":[{"id":"A193","pred":"fma_id","subj":"T193","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"• Prospective, open-label, pilot study\n• ‘CytoSorb’ polystyrene-based hemoadsorber to adsorb circulating cytokines\n• N = 40–50 ‘CytoSorb’\n• N = 40–50 standard care\n• Primary outcome is time to resolution of vasoplegic shock"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T273","span":{"begin":20,"end":25},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":"• Prospective, open-label, pilot study\n• ‘CytoSorb’ polystyrene-based hemoadsorber to adsorb circulating cytokines\n• N = 40–50 ‘CytoSorb’\n• N = 40–50 standard care\n• Primary outcome is time to resolution of vasoplegic shock"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T316","span":{"begin":20,"end":25},"obj":"Chemical"},{"id":"T317","span":{"begin":52,"end":63},"obj":"Chemical"}],"attributes":[{"id":"A316","pred":"chebi_id","subj":"T316","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"},{"id":"A317","pred":"chebi_id","subj":"T317","obj":"http://purl.obolibrary.org/obo/CHEBI_53276"}],"text":"• Prospective, open-label, pilot study\n• ‘CytoSorb’ polystyrene-based hemoadsorber to adsorb circulating cytokines\n• N = 40–50 ‘CytoSorb’\n• N = 40–50 standard care\n• Primary outcome is time to resolution of vasoplegic shock"}

{"project":"LitCovid-sentences","denotations":[{"id":"T309","span":{"begin":39,"end":114},"obj":"Sentence"},{"id":"T310","span":{"begin":115,"end":138},"obj":"Sentence"},{"id":"T311","span":{"begin":139,"end":164},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"• Prospective, open-label, pilot study\n• ‘CytoSorb’ polystyrene-based hemoadsorber to adsorb circulating cytokines\n• N = 40–50 ‘CytoSorb’\n• N = 40–50 standard care\n• Primary outcome is time to resolution of vasoplegic shock"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T155","span":{"begin":219,"end":224},"obj":"Phenotype"}],"attributes":[{"id":"A155","pred":"hp_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/HP_0031273"}],"text":"• Prospective, open-label, pilot study\n• ‘CytoSorb’ polystyrene-based hemoadsorber to adsorb circulating cytokines\n• N = 40–50 ‘CytoSorb’\n• N = 40–50 standard care\n• Primary outcome is time to resolution of vasoplegic shock"}